<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03944330</url>
  </required_header>
  <id_info>
    <org_study_id>Nstlf</org_study_id>
    <nct_id>NCT03944330</nct_id>
  </id_info>
  <brief_title>A Study on Nutrition Support Therapy of Patients With Liver Failure</brief_title>
  <official_title>A Clinic Trail on Nutrition Support Therapy of Patients With Liver Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a Clinical trial to assess the efficacy of nutrition support therapy of
      patients with liver failure. Patients were randomized to one of 2 groups to receive different
      nutrition and energy support treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with liver failure (defined by APASL) induced by any precipitating factors were
      randomized to two groups; a treatment group and a control group. Participants in treatment
      group were provided with a standard hospital diet that provided 25-30 kcal/kg/day . Patients
      in control group receive diet guide
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 10, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality at 30 day</measure>
    <time_frame>4 weeks</time_frame>
    <description>The percentage of death of liver failure patients at 4 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>liver transplant-free survival</measure>
    <time_frame>3month</time_frame>
    <description>survival rate on 4 weeks and 3 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory variables on serum biochemistry markers</measure>
    <time_frame>3month</time_frame>
    <description>Laboratory variables on serum lever of glutamic-pyruvic transaminase/glutamic oxalacetic transaminase/total bilirubin/ cholinesterase will be combined to report liver function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory variables on fasting blood sugar</measure>
    <time_frame>3month</time_frame>
    <description>Laboratory variables on serum lever of fasting blood sugar</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Nutrition</condition>
  <arm_group>
    <arm_group_label>a treatment group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All study participants were provided with a standard hospital diet that provided B25-30 kcal/kg/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>All study participants were not intervened with diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>standard hospital diet</intervention_name>
    <description>patients were provided standard hospital diet that provided 25-30 kcal/kg/day</description>
    <arm_group_label>a treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female patients from 18 to 65 years of age;

          2. Patient inclusion criteria: jaundice (serum total bilirubin ≥5 mg/dl) and coagulopathy
             (INR ≥ 1.5 or prothrombin activity ≥ 40 %), accompanied by ascites and/or
             encephalopathy within 4 weeks.

        Exclusion Criteria:

          1. Surgery with in 4 weeks

          2. three degree hepatoencephalopathy

          3. malignant tumors

          4. cardiac failure or respiratory failure

          5. liver transplantation within observing period -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>March 14, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Qin Ning</investigator_full_name>
    <investigator_title>Director and Chair of Department of Infectious Diseases</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

